Sarepta Therapeutics
SRPT
#5161
Rank
โ‚น164.95 B
Marketcap
โ‚น1,538
Share price
-4.76%
Change (1 day)
0.41%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Sarepta Therapeutics (SRPT) - Net assets

Net assets on the balance sheet as of June 2026 : โ‚น143.12 Billion

According to Sarepta Therapeutics 's latest financial reports the company has โ‚น143.12 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Sarepta Therapeutics - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$โ‚น71.53 B124.58%
2022-12-31$โ‚น31.85 B-53.88%
2021-12-31$โ‚น69.07 B23.99%
2020-12-31$โ‚น55.71 B-4.52%
2019-12-31$โ‚น58.34 B-19.17%
2018-12-31$โ‚น72.17 B43.24%
2017-12-31$โ‚น50.39 B120.25%
2016-12-31$โ‚น22.87 B80.87%
2015-12-31$โ‚น12.64 B-19.41%
2014-12-31$โ‚น15.69 B2.78%
2013-12-31$โ‚น15.27 B125.52%
2012-12-31$โ‚น6.77 B312.71%
2011-12-31$โ‚น1.64 B-1399.85%
2010-12-31$-โ‚น0.13 Billion-111.51%
2009-12-31$โ‚น1.09 B45%
2008-12-31$โ‚น0.75 B-26.97%
2007-12-31$โ‚น1.03 B-38.01%
2006-12-31$โ‚น1.67 B-30.83%
2005-12-31$โ‚น2.41 B112.25%
2004-12-31$โ‚น1.13 B-42.42%
2003-12-31$โ‚น1.97 B75.46%
2002-12-31$โ‚น1.12 B-23.57%
2001-12-31$โ‚น1.47 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Gilead Sciences
GILD
โ‚น1.100 T 668.69%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
-โ‚น15.5 Billion-110.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-โ‚น17.87 Billion-112.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น337.60 B 135.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Insmed
INSM
โ‚น68.03 B-52.47%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚น42.56 Billion-129.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
โ‚น158.18 B 10.52%๐Ÿ‡บ๐Ÿ‡ธ USA